<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00564759</url>
  </required_header>
  <id_info>
    <org_study_id>58/59</org_study_id>
    <secondary_id>DeReG 31</secondary_id>
    <secondary_id>KSG 31</secondary_id>
    <nct_id>NCT00564759</nct_id>
  </id_info>
  <brief_title>Gene Therapy for Chronic Granulomatous Disease</brief_title>
  <acronym>CGD</acronym>
  <official_title>Phase I/II Gene Therapy Study for X-Linked Chronic Granulomatous Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the side effects and risks after infusion of retroviral
      gene corrected autologous CD34+ cells of the peripheral blood of chemotherapy conditioned
      (busulphan)patients with chronic granulomatous disease (CGD). Also gene corrected and
      functional active granulocytes in the peripheral blood and the engraftment in the bone marrow
      of the patients will be monitored an documented.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2004</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>safety, toxicity and feasibility</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Engraftment of gene corrected stem cells, functional reconstitution of respiratory burst, clinical benefit</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">2</enrollment>
  <condition>Granulomatous Disease, Chronic</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>retroviral SF71-gp91phox transduced CD34+ cells</intervention_name>
    <description>autologous ex-vivo retroviral transduced (SF71-gp91phox) CD34+ cells</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  x-linked Chronic Granulomatous Disease

          -  history of life-threatening severe infections

          -  no HLA-matched related or non-related donor

          -  therapy resistent life threatening infections/organ dysfunction

          -  no other treatment options e.g. BMT

        Exclusion Criteria:

          -  &lt; 18 years of age

          -  HIV infection

          -  life expectancy &gt; 2 years

          -  infections treatable by conventional therapy (antibiotics, allogeneic granulocytes)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dieter Hoelzer, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Hematology</name>
      <address>
        <city>Frankfurt</city>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006 Apr;12(4):401-9. Epub 2006 Apr 2.</citation>
    <PMID>16582916</PMID>
  </results_reference>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2007</study_first_submitted>
  <study_first_submitted_qc>November 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2007</study_first_posted>
  <last_update_submitted>November 27, 2007</last_update_submitted>
  <last_update_submitted_qc>November 27, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2007</last_update_posted>
  <keyword>CGD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Granuloma</mesh_term>
    <mesh_term>Granulomatous Disease, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

